EVGN:NASDAQ
Evogene Ltd
US$0.39
0.00%
(0.00) 1 天
US$0.39
arrow_upward
+0.91% (+0.0035)today开盘前
休市： 10月12日, GMT-4 16:00:00 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 EVGN 生成关键数据洞见…
市值
701.79万
平均成交量
256.96万
成交量
7383.00
52 周最高价
US$1.49
52 周最低价
US$0.35
每股收益
-US$0.90
Beta 版
1.44
流通股数
1805.30万
员工人数
52
市值
701.79万
平均成交量
256.96万
成交量
7383.00
52 周最高价
US$1.49
52 周最低价
US$0.35
每股收益
-US$0.90
Beta 版
1.44
流通股数
1805.30万
员工人数
52
新闻报道
来自网络来源和新闻合作伙伴
TradingKey
·
1天前
道指升近200点，费半跌超2%；记忆体股跌幅居前；美光跌逾4%，Meta升超3%
www.tmgm.com
·
16小时前
道琼斯工业平均指数小幅走高，因无存储芯片可供出售
FOREX.com
·
18小时前
油价与美元齐涨 道琼斯指数逆势三连阳
Traders Union
·
1天前
Ryan Detrick指出，S&P 500自2019年以来的涨幅主要由盈利和股息推动
资料
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Evogene Ltd简介